← Back to all signals
RESEARCH PAPER ANALYSIS

Does the charitable medical assistance program impact catastrophic medical expenditures for families of children with leukemia? An evidence-based study in China.

AI interpretation is pending for this paper.

Open original publication →
PMID40091078
JournalInternational journal for equity in health
Publication Date2025-03-17
Ingested2026-08-02 12:04 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Pediatric leukemia is the most prevalent childhood cancer in China, exerting a considerable financial impact on affected families. Despite the mandatory participation of all Chinese children in the Resident Basic Medical Insurance, out-of-pocket (OOP) expenses remain substantial for families of children with leukemia. However, charity assistance has been shown to help mitigate these financial burdens. The "Love Union Project" is a comprehensive charitable medical assistance program designed to support families of children with leukemia within China's multi-tiered healthcare security system. This study was designed to evaluate the impact of the "Love Union Project" on reducing the incidence of catastrophic health expenditure (CHE) among families of children with leukemia in China. METHODS: The study involved 85 children in the intervention group from H city and 36 matched control children from S and Y cities. Data on demographics, medical expenses, and assistance were collected. Non-normally distributed costs were reported as medians. Multivariate logistic regression analyzed the impact of the "Love Union Project" on CHE. RESULTS: Thanks to the program's intervention, the CHE rate among the intervention group decreased from 75.3% to 65.9%, while the incidence of CHE in the control group was 75.0%. Compared to families with children aged 0-6 years, those aged 7-12 were more likely to incur CHE (OR 5.224; 95% confidence intervals 1.412-19.322). Families with five or more members were also at higher risk of CHE than those with four members or fewer (OR 2.847; 95% confidence intervals 1.056-7.676). Additionally, families with a monthly income of CNY8000($1,120) or more were less likely to experience CHE than those with a monthly income of CNY4000($560) or less (OR 0.257; 95% confidence intervals 0.072-0.923). Lastly, families receiving assistance from the "Love Union Project" reported significantly lower CHE rates than those who didn't receive such support (OR 0.151; 95% confidence intervals 0.044-0.524). CONCLUSION: While medical insurance provides limited relief, the "Love Union Project" enhances economic resilience for families of children with leukemia. Attention should focus on younger patients, larger households, lower-income families, and those not receiving charity support.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Age- and Sex-Related Differences in Primary Cutaneous Lymphoma. Cutis 59.4 2 Evaluating the consequences of childhood adiposity on the human plasma proteome at four timepoints across the lifecourse. Nature communications 38.2 3 CReP-mediated control of eIF2α phosphorylation is a critical node in MYC-driven medulloblastoma. Nature communications 58.4 4 DICER1 genetics and their impact on the diagnosis and management of lung lesions: A scoping review. Paediatric respiratory reviews 63.4 5 Sex- and age-stratified pharmacovigilance of methotrexate-associated adverse events in pediatric leukemia: a FAERS-based study. Frontiers in medicine 66.72 6 Case Report: Dasatinib-associated chylothorax and occult Bartonella henselae infection in pediatric leukemia: a case report and systematic review. Frontiers in pharmacology 75.6 7 B7-H3-mediated immune regulation in cancer: biological functions and therapeutic opportunities. Frontiers in pharmacology 67.04 8 Machine learning prediction model for distant metastasis at diagnosis in pediatric neuroblastoma: development, interpretation, and temporal validation. Translational pediatrics 73.3 9 Lipid and immune profiles in children with systemic juvenile idiopathic arthritis: a case-control study with paired longitudinal comparison of disease activity. Translational pediatrics 71.0 10 Ethical dilemmas and intervention strategies in doctor-patient-family communication in end-of-life pediatric oncology: a narrative review. Translational pediatrics 63.6 11 Pediatric Large Cell/Anaplastic Medulloblastomas: Diagnostic Concordance and Multi-Classifier DNA Methylation Profiling, Including the In-House MAGIBU Framework. Neuropathology : official journal of the Japanese Society of Neuropathology 64.5 12 Under One Roof: Household Composition and Health-Related Quality of Life Among Cancer Survivors. Cancer medicine 65.5 13 The Role of Methylation Marker FAM19A4/mir124-2 and HPV Genotype in Active Surveillance of Women With Cervical Intraepithelial Neoplasia Grade 2 (CIN2). Journal of medical virology 71.9 14 Pediatric Liver Transplantation in the Treatment of Solid Liver Tumors: A Narrative Review. Pediatric transplantation 64.84 15 Medulloblastoma Spatial Transcriptomics Reveals Tumor Microenvironment Heterogeneity With High-Density Progenitor Cell Regions Correlating With High-Risk Disease. JCO precision oncology 65.6 16 From Cure to Quality of Life: The Shifting Frontier in Pediatric Acute Lymphoblastic Leukemia. Journal of the National Comprehensive Cancer Network : JNCCN 47.5 17 Adverse Family Outcomes in Children With B-Cell Acute Lymphoblastic Leukemia From the Multicenter Trial Children's Oncology Group AALL0932. Journal of the National Comprehensive Cancer Network : JNCCN 72.7 18 Pediatric conjunctival papilloma managed with staged multimodal therapy: a case report. BMC ophthalmology 50.74 19 Where Eastern Medicine Meets Western Medicine: A World Review of the Management of Chronic Cough. World journal of otorhinolaryngology - head and neck surgery 65.5 20 Nanoprobe-Enabled Precision Imaging and Panoramic Boundary Delineation in Retinoblastoma. Cancer innovation 63.5 21 Bridging therapy in pediatric and AYA patients under 25 years with relapsed/refractory B-ALL undergoing anti-CD19 CAR-T therapy: a multicenter retrospective study by the Spanish group GETH-TC. Bone marrow transplantation 82.98 22 Changes in pediatric oncology nurses' knowledge and observed mucormycosis-prevention practices following an educational programme: a one-group pretest-posttest study. BMC nursing 80.4 23 Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastoma. Cell reports 59.3 24 Atypical presacral masses in Currarino syndrome: a case series. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 54.5 25 First report of proven Fusarium brachygibbosum sinusitis in a paediatric patient with acute myeloblastic leukaemia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 55.2 26 Interpreting the Association Between Plasma Citrulline and Bloodstream Infection in Pediatric Acute Myeloid Leukemia. European journal of haematology 47.5 27 Trust in Retinoblastoma Care: Understanding Parent-Physician Relationships in Collectivist, Low-Resource Settings. Pediatric blood & cancer 60.9 28 Combined Bulk and Single-Cell RNA Sequencing Reveals Alterations in the Immune Microenvironment and Candidate Immune-Related Genes Associated With Diagnosis and Relapse in Childhood B-Cell Acute Lymphoblastic Leukemia. Pediatric blood & cancer 60.32 29 Phase II study of selpercatinib in children and young adults with RET-altered tumors: Arm N of the NCI-COG Pediatric MATCH trial (APEC1621). The oncologist 81.9 30 Genetic insights into pediatric congenital pulmonary airway malformations: a 13-year single-center experience. Pediatric surgery international 61.9 31 A case report of pediatric Gardner syndrome and literature review. Skeletal radiology 51.1 32 Changes In body composition and subsequent risk of relapse In childhood hodgkin lymphoma. Journal of the National Cancer Institute 73.92
PATIENT-FRIENDLY SUMMARY

Does the charitable medical assistance program impact catastrophic medical expenditures for families of children with leukemia? An evidence-based study in China.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic